Introduction Idiopathic pulmonary fibrosis (IPF) is a disease of high morbidity and mortality. We previously identified a novel subset of pathological fibroblasts, characterised by CTHRC1 expression, ...

Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe and potentially fatal complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Early identification ...

Tiger Woods was not in his right frame of mind. Tiger Woods is being flooded with fresh memories of what happened the day he got arrested after flipping his SUV. Woods failed sobriety tests, his eyes ...

👉 Learn how to evaluate the tangent of an angle in degrees using the sum/difference formulas. To do this, we first express the given angle as a sum or a difference of two (easy to evaluate) angles, ...

👉 Learn how to evaluate the cosine of an angle in radians using the sum/difference formulas. To do this, we first express the given angle as a sum or a difference of two (easy to evaluate) angles, ...

Here is a recap of what happened in the search forums today, through the eyes of the Search Engine Roundtable and other search forums on the web. OpenAI is testing ChatGPT ads maybe in the form of ...

We aimed to quantify the incidence of atrial fibrillation (AF) in patients with cryptogenic stroke globally, as well as separately in patients in and outside of Japan, using an implantable loop ...

Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...

Shares of Abbott Laboratories (ABT) have seen a small negative price reaction in response to a larger deal for its smaller diagnostic peer Exact Sciences Corporation (EXAS), taking place at a revenue ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

The pending $23 billion sale of Madison-based Exact Sciences to health care giant Abbott centers on Exact Sciences' flagship product: colorectal cancer test Cologuard. Exact Sciences markets Cologuard ...